Monkeypox: A Re-emerging Viral Zoonotic Infection
Open Access
- 12 November 2022
- journal article
- research article
- Published by Brieflands in Annals of Military and Health Sciences Research
- Vol. 20 (3)
Abstract
Context: Monkeypox virus (MPXV) infection is a zoonotic disease, endemic in sub-Saharan Africa, but recently has re-emerged outside Africa and caused some concerns. Evidence Acquisition: The current study aimed to briefly present a narrative mini-review on different features of MPXV. Data were gathered from Google Scholar, ScienceDirect, and PubMed databases and also WHO and CDC websites, using ''Monkeypox'', ''Variola'', ''Bioterrorism'', and ''Bioweapon'' keywords. Results: Monkeypox virus is categorized into two genetic clades with different outcomes. The incubation period of infection is 5 - 21 days, and infection by Central African clade may lead to a clinical representation similar to smallpox with about 10% mortality rate. Monkeypox virus can infect a wide range of mammals, and its natural reservoir is almost unknown. It is endemic in sub-Saharan Africa and is rarely seen outside Africa. Its most reliable detection is based on nucleic acid amplification tests (NAATs). Treatment is mainly supportive, and some selective drugs are developed for severe cases. Avoiding close contact with wild animals and infected patients is the first line of prevention. Prior vaccination with smallpox or MPX vaccines is also protective. Due to similar symptoms of human monkeypox and smallpox, it may be a candidate for bioterrorism. However, there is no evidence of recent intentional spread of MPXV. Conclusions: This study has tried to provide a summary of MPXV infection. Despite recent concerns, there is still a very low risk of the MPXV pandemic. However, it is recommended to be alert for such infection and provide essential readiness against it.Keywords
This publication has 17 references indexed in Scilit:
- Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in HumansFrontiers in Public Health, 2018
- Oral Tecovirimat for the Treatment of SmallpoxNew England Journal of Medicine, 2018
- Human MonkeypoxClinical Infectious Diseases, 2013
- Nonhuman Primates Are Protected from Smallpox Virus or Monkeypox Virus Challenges by the Antiviral Drug ST-246Antimicrobial Agents and Chemotherapy, 2009
- Progress in the Discovery of Compounds Inhibiting Orthopoxviruses in Animal ModelsAntiviral Chemistry and Chemotherapy, 2008
- Human Monkeypox: An Emerging Zoonotic DiseaseFuture Microbiology, 2007
- Reemergence of Monkeypox: Prevalence, Diagnostics, and CountermeasuresClinical Infectious Diseases, 2005
- Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infectionsAntiviral Research, 2003
- Outbreak of Human Monkeypox, Democratic Republic of Congo, 1996 to 1997Emerging Infectious Diseases, 2001
- Poxvirus Dilemmas — Monkeypox, Smallpox, and Biologic TerrorismNew England Journal of Medicine, 1998